The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...

A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where Arbutus Biopharma Corp.

The Nasdaq is one of the top three most-followed stock market indices in the United States, comprising over 2,500 stocks.

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B. Most patients recovering from acute hepatitis B clear HBsAg within 4-6 months after onset ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...

Aligos Therapeutics (ALGS) has entered into a securities purchase agreement for a private placement that is expected to result in gross ...